← Back to Search

Exercise + Prebiotic for Obesity (GAMEPLAN Trial)

N/A
Recruiting
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & 6-week mark

Summary

This trial is testing how taking a special type of fiber and doing regular exercise can improve gut health and overall well-being. It targets people who want to boost their gut health. The fiber feeds good bacteria in the gut, and exercise keeps the body healthy.

Eligible Conditions
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 6-week mark
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & 6-week mark for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in gastrointestinal microbial-derived metabolite concentrations
Changes in gastrointestinal microbiota composition
Secondary study objectives
Changes in body composition
Changes in body fat distribution
Changes in cognition
+2 more
Other study objectives
Changes in lipid profiles

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise + PrebioticExperimental Treatment2 Interventions
The Exercise + Prebiotic intervention group will consume 10 g/d of fructo-oligosaccharides (FOS). Additionally, they will perform 6 wk. of supervised progressive multi-component exercise training consisting of moderate to vigorous aerobic and strength-based exercises (3x/wk).
Group II: Exercise + PlaceboPlacebo Group2 Interventions
The Exercise + Placebo group will consume 10 g/d of a placebo (maltodextrin) powder every day. Additionally, they will perform 6 wk. of supervised progressive multi-component exercise training consisting of moderate to vigorous aerobic and strength-based exercises (3x/wk).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~820

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
197 Previous Clinical Trials
38,227 Total Patients Enrolled
26 Trials studying Obesity
2,585 Patients Enrolled for Obesity

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05207488 — N/A
Obesity Research Study Groups: Exercise + Prebiotic, Exercise + Placebo
Obesity Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT05207488 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05207488 — N/A
~12 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top